Production (Stage)
Goldenwell Biotech, Inc.
GWLL
$0.20
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00% | -- | -66.67% | -85.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00% | -- | -66.67% | -85.71% |
| Cost of Revenue | -- | -200.00% | -- | 0.00% | -- |
| Gross Profit | -- | 75.00% | -- | 0.00% | -- |
| SG&A Expenses | 11.38% | -1.55% | -35.11% | 83.82% | -15.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.38% | -2.56% | -35.47% | 82.85% | -17.14% |
| Operating Income | -11.38% | 3.05% | 34.75% | -84.13% | 13.69% |
| Income Before Tax | -10.61% | -29.11% | 34.75% | -84.13% | 7.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.61% | -29.11% | 34.75% | -84.13% | 7.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.61% | -29.11% | 34.75% | -84.13% | 7.44% |
| EBIT | -11.38% | 3.05% | 34.75% | -84.13% | 13.69% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00% | -50.00% | 50.00% | -66.67% | 0.00% |
| Normalized Basic EPS | 0.00% | -100.00% | 50.00% | -50.00% | 0.00% |
| EPS Diluted | 0.00% | -50.00% | 50.00% | -66.67% | 0.00% |
| Normalized Diluted EPS | 0.00% | -100.00% | 50.00% | -50.00% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 2.66% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 2.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |